Allogene Therapeutics Plans to Raise $500 Million Through Sale of Securities
Thursday, 14 March 2024, 21:37
Allogene Therapeutics Files for $500M Mixed Shelf
Allogene Therapeutics intends to raise $500 million by selling various securities, as outlined in its recent SEC filing. The company aims to utilize the funds to support strategic growth initiatives and strengthen its financial position for future endeavors.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.